Survivin is highly expressed in various malignancies and functions as an inhibitor of apoptosis. YM155, an imidazolium-based small molecule, has potent inhibitory activity to survivin; therefore, it is considered a potential new class of anti-tumor agents. In the current study, we screened for various canine tumor cell lines that have susceptibility to YM155. On the basis of the screening, we focused on squamous cell carcinoma (SCC) and growth inhibitory mechanisms of YM155 in SCC cells were investigated.
Among ten cell lines (eight tumor types) screened, only SCC cell line showed substantial susceptibility to YM155. Based on this finding, seven canine SCC cell lines were examined for susceptibility to the cytotoxic effects of YM155. YM155 clearly inhibited the growth of two cell lines HAPPY and SQ4. These cell lines, but not other cell lines, highly expressed survivin. In HAPPY cells, YM155 inhibited expression of survivin at the both mRNA and protein level. In contrast, YM155 down-regulated survivin expression only at the protein level in SQ4 cells. Moreover, YM155 suppressed cell growth mostly by induction of apoptosis in HAPPY cells but not in SQ4 cells.
Nippon veterinary and life science university
Thursday, June 14
3:15 PM – 3:30 PM
The asset you are trying to access is locked. Please enter your access key to unlock.